Related Experiment Video
Updated: Nov 22, 2025

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
Five-year retrospective review in gynecologic cytopathology: is it time to amend?
Laila Nomani1, Schuharazad Abro1, Grazina Chatt1
1Department of Pathology and Laboratory Medicine, Loyola University Healthcare System, Maywood, Illinois.
Introduction:
According to the Clinical Laboratory Improvement Amendments 1988 regulations, 5-year retrospective review (5YRR) of normal Papanicolaou tests in patients with a newly diagnosed high grade squamous intraepithelial lesion or above (HSIL+) is mandatory. Since this mandate has been in place, a multitude of changes have taken place in the screening and management guidelines of cervical cancer. The aim of this study is to assess the role of this mandate in our laboratory and to investigate the lessons learned.
Material And Methods:
The cytopathology electronic database and institutional quality assurance records at Loyola University Medical Center were searched from January 2009 to December 2019 to identify all Papanicolaou tests diagnosed as new "HSIL and above" (HSIL+). Major discrepancy (2+) was defined as initial negative diagnosis changed to HSIL+.
Results:
A total of 153,083 Papanicolaou tests were performed during this period; out of these, 1452 (0.94%) were diagnosed as HSIL+. A total of 695 HSIL+ Papanicolaou tests had a negative prior Papanicolaou and in 615 of 695 there was agreement with the initial negative diagnosis. In 61 Papanicolaou tests, the initial diagnosis was changed from negative and they were reclassified on review as 3 HSIL, 9 ASC-H, 7 AGC, and 42 ASCUS or LSIL. Major discrepancy rate was calculated as 3 of 695 (0.43%). None required an amended report.
Conclusions:
It is important to revisit the 5YRR as a method of implementing the quality indicators in gynecologic cytology so that the process retains its value without overburdening cytology laboratories and personnel.
Insights
The mandatory 5-year retrospective review (5YRR) of Papanicolaou tests for high-grade squamous intraepithelial lesions (HSIL+) showed a low major discrepancy rate of 0.43%. This review process is crucial for quality assurance in gynecologic cytology.
Area of Science:
- Cytopathology
- Gynecologic Oncology
- Quality Assurance in Healthcare
Background:
- The Clinical Laboratory Improvement Amendments of 1988 mandate a 5-year retrospective review (5YRR) of normal Papanicolaou tests for patients with newly diagnosed high-grade squamous intraepithelial lesions or above (HSIL+).
- Significant advancements in cervical cancer screening and management guidelines have occurred since this mandate was implemented.
- The value and efficiency of this mandatory review process in modern cytopathology practice require assessment.
Purpose of the Study:
- To evaluate the role and impact of the mandatory 5YRR in identifying discrepancies within a specific laboratory setting.
- To investigate the practical lessons learned from implementing the 5YRR in accordance with current cervical cancer screening protocols.
- To assess the overall effectiveness of the 5YRR as a quality indicator in gynecologic cytology.
Main Methods:
- A retrospective search of the cytopathology electronic database and quality assurance records was conducted at Loyola University Medical Center.
- The study period spanned from January 2009 to December 2019, identifying all Papanicolaou tests diagnosed as HSIL+.
- Major discrepancies were defined as initial negative diagnoses subsequently changed to HSIL+ upon review.
Main Results:
- Out of 153,083 Papanicolaou tests, 1452 (0.94%) were diagnosed as HSIL+.
- Among 695 HSIL+ cases with prior negative Papanicolaou tests, 615 showed agreement.
- A major discrepancy rate of 0.43% (3 out of 695 cases) was observed, with no amended reports required.
Conclusions:
- The 5-year retrospective review (5YRR) process, while mandatory, yielded a low rate of major discrepancies in this study.
- Revisiting the 5YRR is essential to ensure its continued value as a quality indicator in gynecologic cytology.
- Optimizing the 5YRR process is necessary to maintain its effectiveness without imposing an undue burden on cytology laboratories and personnel.
Related Concept Videos
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies VI: Voiding Cystourethrography and Cystography
Histology of the Uterus
The endometrium is the...

